1	A	A	B-NP	DT	O	3	NMOD	-1
2	novel	novel	I-NP	JJ	O	3	NMOD	-1
3	role	role	I-NP	NN	O	0	ROOT	0
4	of	of	B-PP	IN	O	3	NMOD	-1
5	thrombospondin-1	thrombospondin-1	B-NP	NN	B-protein	4	PMOD	-1
6	in	in	B-PP	IN	O	3	NMOD	-1
7	cervical	cervical	B-NP	JJ	O	8	NMOD	-1
8	carcinogenesis	carcinogenesis	I-NP	NN	O	6	PMOD	0
9	:	:	O	:	O	3	P	-1
10	inhibit	inhibit	B-VP	VB	O	3	NMOD	18	inhibit
11	stroma	stroma	B-NP	NN	O	12	NMOD	-1
12	reaction	reaction	I-NP	NN	O	10	OBJ	-1
13	by	by	B-PP	IN	O	3	NMOD	-1
14	inhibiting	inhibit	B-VP	VBG	O	13	PMOD	18	inhibiting
15	activated	activate	B-NP	VBN	B-cell_type	16	NMOD	17	activated
16	fibroblasts	fibroblast	I-NP	NNS	I-cell_type	14	OBJ	-1
17	from	from	B-PP	IN	O	14	VMOD	-1
18	invading	invade	B-VP	VBG	O	17	PMOD	14	invading
19	cancer	cancer	B-NP	NN	O	18	OBJ	-1
20	.	.	O	.	O	3	P	-1

1	Thrombospondin	Thrombospondin	B-NP	NN	B-protein	3	NMOD	-1
2	(	(	O	(	O	3	NMOD	-1
3	TSP	TSP	B-NP	NN	O	10	NMOD	-1
4	)	)	O	)	O	3	NMOD	-1
5	-1	-1	B-NP	CD	O	3	NMOD	-1
6	,	,	O	,	O	10	P	-1
7	a	a	B-NP	DT	O	10	NMOD	-1
8	potent	potent	I-NP	JJ	O	10	NMOD	-1
9	angiogenesis	angiogenesis	I-NP	NN	O	10	NMOD	3	angiogenesis
10	inhibitor	inhibitor	I-NP	NN	O	12	SUB	0
11	,	,	O	,	O	10	P	-1
12	has	have	B-VP	VBZ	O	0	ROOT	-1
13	been	be	I-VP	VBN	O	12	VC	-1
14	shown	show	I-VP	VBN	O	13	VC	-1
15	to	to	I-VP	TO	O	16	VMOD	-1
16	exert	exert	I-VP	VB	O	14	VMOD	-1
17	different	different	B-NP	JJ	O	19	NMOD	-1
18	biological	biological	I-NP	JJ	O	19	NMOD	-1
19	functions	function	I-NP	NNS	O	16	OBJ	0
20	on	on	B-PP	IN	O	16	VMOD	-1
21	various	various	B-NP	JJ	O	23	NMOD	-1
22	cell	cell	I-NP	NN	O	23	NMOD	-1
23	types	type	I-NP	NNS	O	20	PMOD	-1
24	.	.	O	.	O	12	P	-1

1	Here	Here	B-ADVP	RB	O	4	VMOD	-1
2	,	,	O	,	O	4	P	-1
3	we	we	B-NP	PRP	O	4	SUB	-1
4	investigate	investigate	B-VP	VBP	O	0	ROOT	-1
5	the	the	B-NP	DT	O	6	NMOD	-1
6	role	role	I-NP	NN	O	4	OBJ	16	role
7	of	of	B-PP	IN	O	6	NMOD	-1
8	TSP-1	TSP-1	B-NP	NN	B-protein	7	PMOD	-1
9	in	in	B-PP	IN	O	6	NMOD	-1
10	tumor-stroma	tumor-stroma	B-NP	NN	O	11	NMOD	-1
11	reaction	reaction	I-NP	NN	O	9	PMOD	15	reaction
12	,	,	O	,	O	6	P	-1
13	which	which	B-NP	WDT	O	6	NMOD	-1
14	is	be	B-VP	VBZ	O	13	SBAR	-1
15	mainly	mainly	I-VP	RB	O	14	VMOD	-1
16	characterized	characterize	I-VP	VBN	O	14	VC	-1
17	by	by	B-PP	IN	O	16	VMOD	-1
18	fibroblast	fibroblast	B-NP	NN	O	19	NMOD	-1
19	activation	activation	I-NP	NN	O	17	PMOD	17	activation
20	to	to	B-VP	TO	O	21	VMOD	-1
21	create	create	I-VP	VB	O	19	NMOD	-1
22	a	a	B-NP	DT	O	24	NMOD	-1
23	permissive	permissive	I-NP	JJ	O	24	NMOD	-1
24	microenvironment	microenvironment	I-NP	NN	O	21	OBJ	-1
25	for	for	B-PP	IN	O	24	NMOD	-1
26	tumor	tumor	B-NP	NN	O	27	NMOD	-1
27	progression	progression	I-NP	NN	O	25	PMOD	2	progression
28	.	.	O	.	O	4	P	-1

1	Immunohistochemistry	Immunohistochemistry	B-NP	NN	O	2	NMOD	-1
2	examinations	examination	I-NP	NNS	O	8	SUB	-1
3	in	in	B-PP	IN	O	2	NMOD	-1
4	the	the	B-NP	DT	O	7	NMOD	-1
5	human	human	I-NP	JJ	O	7	NMOD	-1
6	surgical	surgical	I-NP	JJ	O	7	NMOD	-1
7	specimens	specimen	I-NP	NNS	O	3	PMOD	-1
8	have	have	B-VP	VBP	O	0	ROOT	-1
9	shown	show	I-VP	VBN	O	8	VC	-1
10	that	that	B-SBAR	IN	O	9	VMOD	-1
11	a	a	B-NP	DT	O	12	NMOD	-1
12	downregulation	downregulation	I-NP	NN	O	21	SUB	18	downregulation
13	of	of	B-PP	IN	O	12	NMOD	-1
14	TSP-1	TSP-1	B-NP	NN	B-protein	13	PMOD	-1
15	during	during	B-PP	IN	O	12	NMOD	-1
16	the	the	B-NP	DT	O	17	NMOD	-1
17	progression	progression	I-NP	NN	O	15	PMOD	0
18	of	of	B-PP	IN	O	17	NMOD	-1
19	cervical	cervical	B-NP	JJ	O	20	NMOD	-1
20	carcinogenesis	carcinogenesis	I-NP	NN	O	18	PMOD	0
21	was	be	B-VP	VBD	O	10	SBAR	-1
22	accompanied	accompany	I-VP	VBN	O	21	VC	-1
23	by	by	B-PP	IN	O	22	VMOD	-1
24	an	an	B-NP	DT	O	25	NMOD	-1
25	emergence	emergence	I-NP	NN	O	23	PMOD	-1
26	in	in	B-PP	IN	O	25	NMOD	-1
27	the	the	B-NP	DT	O	28	NMOD	-1
28	upregulation	upregulation	I-NP	NN	O	26	PMOD	17	upregulation
29	of	of	B-PP	IN	O	28	NMOD	-1
30	stroma	stroma	B-NP	NN	B-protein	31	NMOD	-1
31	markers	marker	I-NP	NNS	I-protein	40	NMOD	-1
32	,	,	O	,	O	40	P	-1
33	alpha-smooth	alpha-smooth	B-NP	JJ	B-protein	35	NMOD	-1
34	muscle	muscle	I-NP	NN	I-protein	35	NMOD	-1
35	actin	actin	I-NP	NN	I-protein	40	NMOD	-1
36	(	(	O	(	O	38	DEP	-1
37	alpha-SMA	alpha-SMA	B-NP	NN	B-protein	38	DEP	-1
38	)	)	O	)	O	35	NMOD	-1
39	and	and	O	CC	O	40	NMOD	-1
40	desmin	desmin	B-NP	NN	O	29	PMOD	-1
41	.	.	O	.	O	8	P	-1

1	Transfection	Transfection	B-NP	NN	O	14	SUB	19	Transfection
2	of	of	B-PP	IN	O	1	NMOD	-1
3	SiHa	SiHa	B-NP	NN	B-cell_line	6	NMOD	-1
4	cervical	cervical	I-NP	JJ	I-cell_line	6	NMOD	-1
5	cancer	cancer	I-NP	NN	I-cell_line	6	NMOD	-1
6	cells	cell	I-NP	NNS	I-cell_line	2	PMOD	-1
7	with	with	B-PP	IN	O	1	NMOD	-1
8	a	a	B-NP	DT	O	9	NMOD	-1
9	plasmid	plasmid	I-NP	NN	B-DNA	7	PMOD	-1
10	expressing	express	B-VP	VBG	O	9	NMOD	9	expressing
11	the	the	B-NP	DT	O	13	NMOD	-1
12	TSP-1	TSP-1	I-NP	NN	B-protein	13	NMOD	-1
13	protein	protein	I-NP	NN	I-protein	10	OBJ	-1
14	exhibited	exhibit	B-VP	VBD	O	0	ROOT	0
15	antiangiogenic	antiangiogenic	B-NP	JJ	O	16	NMOD	3	angiogenic
16	activity	activity	I-NP	NN	O	14	OBJ	18	activity
17	in	in	B-ADVP	FW	O	14	VMOD	-1
18	vitro	vitro	I-ADVP	FW	O	17	AMOD	-1
19	and	and	O	CC	O	14	VMOD	-1
20	resulted	result	B-VP	VBD	O	14	VMOD	17	resulted
21	in	in	B-PP	IN	O	20	VMOD	-1
22	reduced	reduce	B-NP	VBN	O	24	NMOD	18	reduced
23	tumor	tumor	I-NP	NN	O	24	NMOD	-1
24	growth	growth	I-NP	NN	O	21	PMOD	4	growth
25	in	in	B-PP	IN	O	24	NMOD	-1
26	severe	severe	B-NP	JJ	O	28	NMOD	-1
27	combined	combined	I-NP	JJ	O	28	NMOD	-1
28	immunodeficiency	immunodeficiency	I-NP	NN	O	32	NMOD	-1
29	(	(	O	(	O	31	DEP	-1
30	SCID	SCID	B-NP	NN	O	31	DEP	-1
31	)	)	O	)	O	28	NMOD	-1
32	mice	mouse	B-NP	NNS	O	25	PMOD	-1
33	,	,	O	,	O	14	P	-1
34	which	which	B-NP	WDT	O	14	VMOD	-1
35	was	be	B-VP	VBD	O	34	SBAR	-1
36	accompanied	accompany	I-VP	VBN	O	35	VC	-1
37	by	by	B-PP	IN	O	36	VMOD	-1
38	a	a	B-NP	DT	O	39	NMOD	-1
39	decrease	decrease	I-NP	NN	O	45	NMOD	18	decrease
40	in	in	B-PP	IN	O	39	NMOD	-1
41	tumor	tumor	B-NP	NN	O	42	NMOD	-1
42	vascularization	vascularization	I-NP	NN	O	40	PMOD	3	vascularization
43	and	and	O	CC	O	45	NMOD	-1
44	lower	low	B-NP	JJR	O	45	NMOD	-1
45	expressions	expression	I-NP	NNS	O	37	PMOD	9	expressions
46	of	of	B-PP	IN	O	45	NMOD	-1
47	alpha-SMA	alpha-SMA	B-NP	NN	B-protein	49	NMOD	-1
48	and	and	I-NP	CC	O	49	NMOD	-1
49	desmin	desmin	I-NP	NN	O	46	PMOD	-1
50	than	than	B-PP	IN	O	36	VMOD	-1
51	those	those	B-NP	DT	O	50	PMOD	-1
52	in	in	B-PP	IN	O	51	NMOD	-1
53	the	the	B-NP	DT	O	55	NMOD	-1
54	vector	vector	I-NP	NN	O	55	NMOD	-1
55	controls	control	I-NP	NNS	O	52	PMOD	0
56	.	.	O	.	O	14	P	-1

1	Transfection	Transfection	B-NP	NN	O	11	SUB	19	Transfection
2	with	with	B-PP	IN	O	1	NMOD	-1
3	TSP-1	TSP-1	B-NP	NN	B-protein	6	NMOD	-1
4	and	and	O	CC	O	6	NMOD	-1
5	purified	purify	B-NP	VBN	O	6	NMOD	0
6	TSP-1	TSP-1	I-NP	NN	B-protein	2	PMOD	-1
7	added	add	B-VP	VBN	O	6	NMOD	19	added
8	to	to	B-PP	TO	O	7	VMOD	-1
9	NIH3T3	NIH3T3	B-NP	NN	B-cell_line	10	NMOD	-1
10	cells	cell	I-NP	NNS	I-cell_line	8	PMOD	-1
11	did	do	B-VP	VBD	O	0	ROOT	-1
12	not	not	I-VP	RB	O	11	VMOD	-1
13	alter	alter	I-VP	VB	O	11	VC	16	alter
14	the	the	B-NP	DT	O	16	NMOD	-1
15	protein	protein	I-NP	NN	O	16	NMOD	-1
16	levels	level	I-NP	NNS	O	13	OBJ	-1
17	of	of	B-PP	IN	O	16	NMOD	-1
18	alpha-SMA	alpha-SMA	B-NP	NN	B-protein	20	NMOD	-1
19	and	and	I-NP	CC	O	20	NMOD	-1
20	desmin	desmin	I-NP	NN	O	17	PMOD	-1
21	but	but	O	CC	O	11	VMOD	-1
22	significantly	significantly	B-VP	RB	O	11	VMOD	-1
23	inhibited	inhibit	I-VP	VBD	O	11	VMOD	18	inhibited
24	matrix	matrix	B-NP	NN	B-protein	26	NMOD	-1
25	metalloprotease-2	metalloprotease-2	I-NP	NN	I-protein	26	NMOD	-1
26	activity	activity	I-NP	NN	O	23	OBJ	0
27	.	.	O	.	O	11	P	-1

1	Transforming	Transform	B-NP	VBG	B-protein	3	NMOD	-1
2	growth	growth	I-NP	NN	I-protein	3	NMOD	0
3	factor-beta	factor-beta	I-NP	NN	I-protein	10	NMOD	-1
4	(	(	O	(	O	6	DEP	-1
5	TGF-beta	TGF-beta	B-NP	NN	B-protein	6	DEP	-1
6	)	)	O	)	O	3	NMOD	-1
7	,	,	O	,	O	10	P	-1
8	a	a	B-NP	DT	O	10	NMOD	-1
9	major	major	I-NP	JJ	B-protein	10	NMOD	-1
10	factor	factor	I-NP	NN	I-protein	17	SUB	-1
11	in	in	B-PP	IN	O	10	NMOD	-1
12	the	the	B-NP	DT	O	13	NMOD	-1
13	activation	activation	I-NP	NN	O	11	PMOD	17	activation
14	of	of	B-PP	IN	O	13	NMOD	-1
15	fibroblasts	fibroblast	B-NP	NNS	B-cell_type	14	PMOD	-1
16	,	,	O	,	O	10	P	-1
17	increased	increase	B-NP	VBN	O	21	NMOD	17	increased
18	alpha-SMA	alpha-SMA	I-NP	NN	O	21	NMOD	-1
19	and	and	I-NP	CC	O	21	NMOD	-1
20	desmin	desmin	I-NP	NN	O	21	NMOD	-1
21	expression	expression	I-NP	NN	O	24	NMOD	9	expression
22	and	and	O	CC	O	24	NMOD	-1
23	the	the	B-NP	DT	O	24	NMOD	-1
24	ability	ability	I-NP	NN	O	0	ROOT	0
25	of	of	B-PP	IN	O	24	NMOD	-1
26	cell	cell	B-NP	NN	O	27	NMOD	-1
27	migration	migration	I-NP	NN	O	29	NMOD	14	migration
28	and	and	O	CC	O	29	NMOD	-1
29	invasion	invasion	B-NP	NN	O	25	PMOD	14	invasion
30	in	in	B-PP	IN	O	29	NMOD	-1
31	NIH3T3	NIH3T3	B-NP	NN	B-cell_line	32	NMOD	-1
32	cells	cell	I-NP	NNS	I-cell_line	30	PMOD	-1
33	.	.	O	.	O	24	P	-1

1	The	The	B-NP	DT	O	4	NMOD	-1
2	increased	increase	I-NP	VBN	O	4	NMOD	17	increased
3	migration	migration	I-NP	NN	O	4	NMOD	14	migration
4	ability	ability	I-NP	NN	O	8	NMOD	0
5	and	and	O	CC	O	8	NMOD	-1
6	the	the	B-NP	DT	O	8	NMOD	-1
7	invasive	invasive	I-NP	JJ	O	8	NMOD	14	invasive
8	ability	ability	I-NP	NN	O	16	SUB	0
9	into	into	B-PP	IN	O	8	NMOD	-1
10	tumor	tumor	B-NP	NN	O	11	NMOD	-1
11	cluster	cluster	I-NP	NN	O	9	PMOD	-1
12	of	of	B-PP	IN	O	11	NMOD	-1
13	TGF-beta-treated	TGF-beta-treated	B-NP	JJ	B-cell_line	15	NMOD	19	treated
14	NIH3T3	NIH3T3	I-NP	NN	I-cell_line	15	NMOD	-1
15	cells	cell	I-NP	NNS	I-cell_line	12	PMOD	-1
16	were	be	B-VP	VBD	O	0	ROOT	-1
17	dose	dose	B-NP	NN	O	16	PRD	-1
18	dependently	dependently	B-VP	RB	O	19	VMOD	-1
19	inhibited	inhibit	I-VP	VBN	O	17	NMOD	18	inhibited
20	by	by	B-PP	IN	O	19	VMOD	-1
21	TSP-1	TSP-1	B-NP	NN	B-protein	20	PMOD	-1
22	.	.	O	.	O	16	P	-1

1	In	In	B-PP	IN	O	10	VMOD	-1
2	contrast	contrast	B-NP	NN	O	1	PMOD	-1
3	,	,	O	,	O	10	P	-1
4	ectopic	ectopic	B-NP	JJ	O	6	NMOD	-1
5	TSP-1	TSP-1	I-NP	NN	B-protein	6	NMOD	-1
6	expression	expression	I-NP	NN	O	10	SUB	9	expression
7	in	in	B-PP	IN	O	6	NMOD	-1
8	SiHa	SiHa	B-NP	NN	B-cell_line	9	NMOD	-1
9	cells	cell	I-NP	NNS	I-cell_line	7	PMOD	-1
10	has	have	B-VP	VBZ	O	0	ROOT	-1
11	little	little	B-NP	JJ	O	12	NMOD	-1
12	effect	effect	I-NP	NN	O	10	OBJ	16	effect
13	on	on	B-PP	IN	O	10	VMOD	-1
14	the	the	B-NP	DT	O	16	NMOD	-1
15	invasive	invasive	I-NP	JJ	O	16	NMOD	14	invasive
16	ability	ability	I-NP	NN	O	13	PMOD	0
17	of	of	B-PP	IN	O	16	NMOD	-1
18	the	the	B-NP	DT	O	20	NMOD	-1
19	NIH3T3	NIH3T3	I-NP	NN	B-cell_line	20	NMOD	-1
20	cells	cell	I-NP	NNS	I-cell_line	17	PMOD	-1
21	.	.	O	.	O	10	P	-1

1	Together	Together	B-ADVP	RB	O	5	VMOD	-1
2	,	,	O	,	O	5	P	-1
3	our	our	B-NP	PRP$	O	4	NMOD	-1
4	findings	finding	I-NP	NNS	O	5	SUB	-1
5	demonstrate	demonstrate	B-VP	VBP	O	0	ROOT	-1
6	a	a	B-NP	DT	O	8	NMOD	-1
7	novel	novel	I-NP	JJ	O	8	NMOD	-1
8	role	role	I-NP	NN	O	5	OBJ	16	role
9	of	of	B-PP	IN	O	8	NMOD	-1
10	TSP-1	TSP-1	B-NP	NN	B-protein	9	PMOD	-1
11	to	to	B-VP	TO	O	12	VMOD	-1
12	inhibit	inhibit	I-VP	VB	O	8	NMOD	18	inhibit
13	tumor-stroma	tumor-stroma	B-NP	NN	O	14	NMOD	-1
14	reaction	reaction	I-NP	NN	O	12	OBJ	15	reaction
15	that	that	B-NP	WDT	O	14	NMOD	-1
16	could	could	B-VP	MD	O	15	SBAR	-1
17	be	be	I-VP	VB	O	16	VC	-1
18	attributed	attribute	I-VP	VBN	O	17	VC	-1
19	to	to	B-PP	TO	O	18	VMOD	-1
20	the	the	B-NP	DT	O	21	NMOD	-1
21	blockage	blockage	I-NP	NN	O	19	PMOD	18	blockage
22	of	of	B-PP	IN	O	21	NMOD	-1
23	activated	activate	B-NP	VBN	B-cell_type	24	NMOD	17	activated
24	fibroblasts	fibroblast	I-NP	NNS	I-cell_type	22	PMOD	-1
25	from	from	B-PP	IN	O	24	NMOD	-1
26	invading	invade	B-VP	VBG	B-cell_type	28	NMOD	14	invading
27	cancer	cancer	B-NP	NN	I-cell_type	28	NMOD	-1
28	cells	cell	I-NP	NNS	I-cell_type	25	PMOD	-1
29	.	.	O	.	O	5	P	-1

